Home > Press Releases > Pharma Supply Chain Digitalization Market

Pharma Supply Chain Digitalization Market Likely to Surpass USD 2.1 Billion by 2035

Report Code: HC-10232  |  Published in: Jul 2026, By MarketGenics  |  Number of pages: 378
Get PDF
Buy

Global Pharma Supply Chain Digitalization Market Forecast 2035:

According to the report, the global pharma supply chain digitalization market is projected to expand from USD 0.9 billion in 2025 to USD 2.1 billion by 2035, registering a CAGR of 8.4%, the highest during the forecast period. The growing need for resilient and data-driven pharmaceutical operations is driving the investments in pharma supply chain digitalization, aimed at increasing the level of visibility, operational agility and supply continuity.  

The use of AI, cloud, automation and serialization is driving a faster and more connected digital supply chain across the pharmaceutical manufacturing and distribution ecosystems. For instance, in May 2025, IBM announced an enhancement of its watsonx AI technology to support businesses in automating supply chain processes, enhancing forecasting, and optimizing operational decisions within intricate supply chains.  

Moreover, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) persistently advocated for enhanced global pharmaceutical supply chains in 2025 through various industry collaboration, digital innovation, and regulatory harmonization initiatives aimed at advancing medicine availability and supply resilience. These advances are fueling the intelligent, agile and resilient transformation of the global pharmaceutical supply chain.                    

Key Driver, Restraint, and Growth Opportunity Shaping the Global Pharma Supply Chain Digitalization Market

The pharma supply chain digitalization market is being fueled by the increasing adoption of digital quality management systems (QMS) that allow for real-time quality monitoring, automated documentation, electronic batch records, and expedient regulatory reporting. The synergy between quality and manufacturing and logistics systems leads to a better level of product consistency, potential risk reduction in compliance and visibility along the entire value chain.                                      

The limited availability of professionals with expertise in AI, cloud platforms, cybersecurity, data analytics, and digital manufacturing slows implementation of advanced supply chain solutions. Integrating new technologies with existing processes, longer deployment times, rising expenses and reliance on external technology partners are all difficulties faced by organizations.                    

The increasing attention on corporate sustainability is driving major opportunities in the digital supply chain platforms to optimize transportation, warehouse operations, energy usage and packaging. With AI sustainability analytics and carbon management solutions, pharmaceutical firms can minimize carbon emissions, optimize resource usage, meet ESG standards, and boost the efficiency of their environmentally friendly supply chain.                                   

Expansion of the Global Pharma Supply Chain Digitalization Market

Integration of Generative AI into Supply Chain Management

  • The adoption of generative AI in the pharmaceutical supply chain is transforming the way the industry operates, from intelligent demand forecasting and inventory optimization to procurement automation and real-time decision support, all the way to predictive risk management, resulting in enhanced supply chain resilience, faster response to disruptions, and optimized end-to-end operational performance for pharmaceutical manufacturers.
  • Generative AI can detect supply chain risks, suggest solutions, and streamline collaboration for more resilient, agile, and data-informed pharmaceutical operations. For instance, in January 2025, Oracle recently announced the introduction of AI agents with roles in Oracle Fusion Cloud Supply Chain & Manufacturing (SCM) to automate repetitive supply chain tasks, provide customized recommendations, and enhance decision-making and productivity across the entire end-to-end supply chain experience with generative AI.
  • Generative AI is driving intelligent automation, supply chain agility, and data-driven decision-making at unprecedented speeds in the pharmaceutical industry.                           

Regional Analysis of Global Pharma Supply Chain Digitalization Market

  • The pharma supply chain digitalization market in North America is expected to grow at high rates as the pharmaceutical industry is well-developed and the adoption of AI, cloud computing, digital twins, and advanced enterprise platforms is early in the region. Investments in smart manufacturing, integrated supply chain ecosystems, and digital quality management help pharmaceutical companies to increase operational efficiency, regulatory compliance, and end-to-end supply chain visibility. North America remains the market leader for pharma supply chain digitalization, with digital maturity continuing to drive the region's lead.
  • Asia Pacific is witnessing the fastest growth with the expansion of pharmaceutical manufacturing, surge in investments in smart factories, and the rapid adoption of artificial intelligence, cloud computing, and automation. The demand for connected supply chain solutions continues to be driven by government mandates for digitalization and increased export of pharmaceuticals.       

Prominent players operating in the global pharma supply chain digitalization market is Blue Yonder Group, Inc., Infosys Limited, International Business Machines Corporation (IBM), Kinaxis Inc., Körber Supply Chain Software GmbH, Manhattan Associates, Inc., Microsoft Corporation, Oracle Corporation, SAP SE, Siemens Digital Industries Software, Tecsys Inc., TraceLink Inc., Wipro Limited, Other Key Players.      

The global pharma supply chain digitalization market has been segmented as follows:

Global Pharma Supply Chain Digitalization Market Analysis, By Component

  • Software
    • Supply Chain Planning & Forecasting Software
    • Inventory & Warehouse Management Software
    • Transportation & Logistics Management Software
    • Track & Trace & Serialization Software
    • Supply Chain Visibility & Analytics Software
    • Quality & Compliance Management Software
    • Others
  • Hardware
    • RFID & Barcode Systems
    • IoT Sensors & Monitoring Devices
    • GPS & Fleet Tracking Devices
    • Mobile Computing Devices
    • Edge Devices & Networking Infrastructure
    • Others
  • Services
    • Consulting & System Integration Services
    • Cloud Implementation & Managed Services
    • Technical Support & Maintenance
    • Data Analytics & Optimization Services
    • Compliance & Training Services
    • Others  

Global Pharma Supply Chain Digitalization Market Analysis, By Deployment Mode

  • Cloud-Based
  • On-Premises
  • Hybrid 

Global Pharma Supply Chain Digitalization Market Analysis, By Technology

  • Artificial Intelligence (AI)
  • Internet of Things (IoT)
  • Blockchain
  • Cloud Computing
  • Big Data Analytics
  • Machine Learning (ML)
  • Robotic Process Automation (RPA)
  • Digital Twin
  • RFID & Barcode Technologies
  • Others  

Global Pharma Supply Chain Digitalization Market Analysis, By Enterprise Size

  • Large Enterprises
  • Medium Enterprises
  • Small Enterprises

Global Pharma Supply Chain Digitalization Market Analysis, By Function

  • Planning & Forecasting
  • Procurement Management
  • Inventory Optimization
  • Logistics & Fleet Management
  • Compliance & Regulatory Management
  • Risk Management
  • Asset Tracking
  • Business Intelligence & Analytics
  • Others

Global Pharma Supply Chain Digitalization Market Analysis, By Application

  • Inventory Management
  • Warehouse Management
  • Cold Chain Monitoring
  • Transportation & Logistics Management
  • Track & Trace
  • Supply Chain Visibility
  • Demand Forecasting
  • Procurement & Supplier Management
  • Order Management
  • Serialization & Anti-Counterfeiting
  • Quality Management
  • Returns & Recall Management
  • Others

Global Pharma Supply Chain Digitalization Market Analysis, By End User

  • Pharmaceutical Manufacturers
  • Biotechnology Companies
  • Contract Manufacturing Organizations (CMOs)
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Third-Party Logistics (3PL) Providers
  • Wholesale Distributors
  • Hospitals & Healthcare Providers
  • Retail & Specialty Pharmacies
  • Others

Global Pharma Supply Chain Digitalization Market Analysis, By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Pharma Supply Chain Digitalization Market Outlook
      • 2.1.1. Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Ecosystem Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. AI, cloud, and automation adoption across pharmaceutical supply chains
        • 4.1.1.2. Digital quality management and connected manufacturing platform adoption
        • 4.1.1.3. Rising drug serialization and end-to-end traceability requirements
      • 4.1.2. Restraints
        • 4.1.2.1. High implementation costs and legacy system integration challenges
        • 4.1.2.2. Shortage of skilled digital and cybersecurity professionals
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Eco-system Analysis         
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Pharma Supply Chain Digitalization Market Demand
      • 4.7.1. Historical Market Size – in Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – in Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Pharma Supply Chain Digitalization Market Analysis, by Component
    • 6.1. Key Segment Analysis
    • 6.2. Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, by Component, 2021-2035
      • 6.2.1. Software
        • 6.2.1.1. Supply Chain Planning & Forecasting Software
        • 6.2.1.2. Inventory & Warehouse Management Software
        • 6.2.1.3. Transportation & Logistics Management Software
        • 6.2.1.4. Track & Trace & Serialization Software
        • 6.2.1.5. Supply Chain Visibility & Analytics Software
        • 6.2.1.6. Quality & Compliance Management Software
        • 6.2.1.7. Others
      • 6.2.2. Hardware
        • 6.2.2.1. RFID & Barcode Systems
        • 6.2.2.2. IoT Sensors & Monitoring Devices
        • 6.2.2.3. GPS & Fleet Tracking Devices
        • 6.2.2.4. Mobile Computing Devices
        • 6.2.2.5. Edge Devices & Networking Infrastructure
        • 6.2.2.6. Others
      • 6.2.3. Services
        • 6.2.3.1. Consulting & System Integration Services
        • 6.2.3.2. Cloud Implementation & Managed Services
        • 6.2.3.3. Technical Support & Maintenance
        • 6.2.3.4. Data Analytics & Optimization Services
        • 6.2.3.5. Compliance & Training Services
        • 6.2.3.6. Others         
  • 7. Global Pharma Supply Chain Digitalization Market Analysis, by Deployment Mode
    • 7.1. Key Segment Analysis
    • 7.2. Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, by Deployment Mode, 2021-2035
      • 7.2.1. Cloud-Based
      • 7.2.2. On-Premises
      • 7.2.3. Hybrid
  • 8. Global Pharma Supply Chain Digitalization Market Analysis, by Technology
    • 8.1. Key Segment Analysis
    • 8.2. Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
      • 8.2.1. Artificial Intelligence (AI)
      • 8.2.2. Internet of Things (IoT)
      • 8.2.3. Blockchain
      • 8.2.4. Cloud Computing
      • 8.2.5. Big Data Analytics
      • 8.2.6. Machine Learning (ML)
      • 8.2.7. Robotic Process Automation (RPA)
      • 8.2.8. Digital Twin
      • 8.2.9. RFID & Barcode Technologies
      • 8.2.10. Others
  • 9. Global Pharma Supply Chain Digitalization Market Analysis, by Enterprise Size
    • 9.1. Key Segment Analysis
    • 9.2. Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, by Enterprise Size, 2021-2035
      • 9.2.1. Large Enterprises
      • 9.2.2. Medium Enterprises
      • 9.2.3. Small Enterprises
  • 10. Global Pharma Supply Chain Digitalization Market Analysis, by Function
    • 10.1. Key Segment Analysis
    • 10.2. Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, by Function, 2021-2035
      • 10.2.1. Planning & Forecasting
      • 10.2.2. Procurement Management
      • 10.2.3. Inventory Optimization
      • 10.2.4. Logistics & Fleet Management
      • 10.2.5. Compliance & Regulatory Management
      • 10.2.6. Risk Management
      • 10.2.7. Asset Tracking
      • 10.2.8. Business Intelligence & Analytics
      • 10.2.9. Others
  • 11. Global Pharma Supply Chain Digitalization Market Analysis, by Application
    • 11.1. Key Segment Analysis
    • 11.2. Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
      • 11.2.1. Inventory Management
      • 11.2.2. Warehouse Management
      • 11.2.3. Cold Chain Monitoring
      • 11.2.4. Transportation & Logistics Management
      • 11.2.5. Track & Trace
      • 11.2.6. Supply Chain Visibility
      • 11.2.7. Demand Forecasting
      • 11.2.8. Procurement & Supplier Management
      • 11.2.9. Order Management
      • 11.2.10. Serialization & Anti-Counterfeiting
      • 11.2.11. Quality Management
      • 11.2.12. Returns & Recall Management
      • 11.2.13. Others
  • 12. Global Pharma Supply Chain Digitalization Market Analysis, by End User
    • 12.1. Key Segment Analysis
    • 12.2. Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
      • 12.2.1. Pharmaceutical Manufacturers
      • 12.2.2. Biotechnology Companies
      • 12.2.3. Contract Manufacturing Organizations (CMOs)
      • 12.2.4. Contract Development and Manufacturing Organizations (CDMOs)
      • 12.2.5. Third-Party Logistics (3PL) Providers
      • 12.2.6. Wholesale Distributors
      • 12.2.7. Hospitals & Healthcare Providers
      • 12.2.8. Retail & Specialty Pharmacies
      • 12.2.9. Others
  • 13. Global Pharma Supply Chain Digitalization Market Analysis, by Region
    • 13.1. Key Findings
    • 13.2. Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 13.2.1. North America
      • 13.2.2. Europe
      • 13.2.3. Asia Pacific
      • 13.2.4. Middle East
      • 13.2.5. Africa
      • 13.2.6. South America
  • 14. North America Pharma Supply Chain Digitalization Market Analysis
    • 14.1. Key Segment Analysis
    • 14.2. Regional Snapshot
    • 14.3. North America Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 14.3.1. Component
      • 14.3.2. Deployment Mode
      • 14.3.3. Technology
      • 14.3.4. Enterprise Size
      • 14.3.5. Function
      • 14.3.6. Application
      • 14.3.7. End User
      • 14.3.8. Country
        • 14.3.8.1. USA
        • 14.3.8.2. Canada
        • 14.3.8.3. Mexico
    • 14.4. USA Pharma Supply Chain Digitalization Market
      • 14.4.1. Country Segmental Analysis
      • 14.4.2. Component
      • 14.4.3. Deployment Mode
      • 14.4.4. Technology
      • 14.4.5. Enterprise Size
      • 14.4.6. Function
      • 14.4.7. Application
      • 14.4.8. End User
    • 14.5. Canada Pharma Supply Chain Digitalization Market
      • 14.5.1. Country Segmental Analysis
      • 14.5.2. Component
      • 14.5.3. Deployment Mode
      • 14.5.4. Technology
      • 14.5.5. Enterprise Size
      • 14.5.6. Function
      • 14.5.7. Application
      • 14.5.8. End User
    • 14.6. Mexico Pharma Supply Chain Digitalization Market
      • 14.6.1. Country Segmental Analysis
      • 14.6.2. Component
      • 14.6.3. Deployment Mode
      • 14.6.4. Technology
      • 14.6.5. Enterprise Size
      • 14.6.6. Function
      • 14.6.7. Application
      • 14.6.8. End User
  • 15. Europe Pharma Supply Chain Digitalization Market Analysis
    • 15.1. Key Segment Analysis
    • 15.2. Regional Snapshot
    • 15.3. Europe Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 15.3.1. Component
      • 15.3.2. Deployment Mode
      • 15.3.3. Technology
      • 15.3.4. Enterprise Size
      • 15.3.5. Function
      • 15.3.6. Application
      • 15.3.7. End User
      • 15.3.8. Country
        • 15.3.8.1. Germany
        • 15.3.8.2. United Kingdom
        • 15.3.8.3. France
        • 15.3.8.4. Italy
        • 15.3.8.5. Spain
        • 15.3.8.6. Netherlands
        • 15.3.8.7. Nordic Countries
        • 15.3.8.8. Poland
        • 15.3.8.9. Russia & CIS
        • 15.3.8.10. Rest of Europe
    • 15.4. Germany Pharma Supply Chain Digitalization Market
      • 15.4.1. Country Segmental Analysis
      • 15.4.2. Component
      • 15.4.3. Deployment Mode
      • 15.4.4. Technology
      • 15.4.5. Enterprise Size
      • 15.4.6. Function
      • 15.4.7. Application
      • 15.4.8. End User
    • 15.5. United Kingdom Pharma Supply Chain Digitalization Market
      • 15.5.1. Country Segmental Analysis
      • 15.5.2. Component
      • 15.5.3. Deployment Mode
      • 15.5.4. Technology
      • 15.5.5. Enterprise Size
      • 15.5.6. Function
      • 15.5.7. Application
      • 15.5.8. End User
    • 15.6. France Pharma Supply Chain Digitalization Market
      • 15.6.1. Country Segmental Analysis
      • 15.6.2. Component
      • 15.6.3. Deployment Mode
      • 15.6.4. Technology
      • 15.6.5. Enterprise Size
      • 15.6.6. Function
      • 15.6.7. Application
      • 15.6.8. End User
    • 15.7. Italy Pharma Supply Chain Digitalization Market
      • 15.7.1. Country Segmental Analysis
      • 15.7.2. Component
      • 15.7.3. Deployment Mode
      • 15.7.4. Technology
      • 15.7.5. Enterprise Size
      • 15.7.6. Function
      • 15.7.7. Application
      • 15.7.8. End User
    • 15.8. Spain Pharma Supply Chain Digitalization Market
      • 15.8.1. Country Segmental Analysis
      • 15.8.2. Component
      • 15.8.3. Deployment Mode
      • 15.8.4. Technology
      • 15.8.5. Enterprise Size
      • 15.8.6. Function
      • 15.8.7. Application
      • 15.8.8. End User
    • 15.9. Netherlands Pharma Supply Chain Digitalization Market
      • 15.9.1. Country Segmental Analysis
      • 15.9.2. Component
      • 15.9.3. Deployment Mode
      • 15.9.4. Technology
      • 15.9.5. Enterprise Size
      • 15.9.6. Function
      • 15.9.7. Application
      • 15.9.8. End User
    • 15.10. Nordic Countries Pharma Supply Chain Digitalization Market
      • 15.10.1. Country Segmental Analysis
      • 15.10.2. Component
      • 15.10.3. Deployment Mode
      • 15.10.4. Technology
      • 15.10.5. Enterprise Size
      • 15.10.6. Function
      • 15.10.7. Application
      • 15.10.8. End User
    • 15.11. Poland Pharma Supply Chain Digitalization Market
      • 15.11.1. Country Segmental Analysis
      • 15.11.2. Component
      • 15.11.3. Deployment Mode
      • 15.11.4. Technology
      • 15.11.5. Enterprise Size
      • 15.11.6. Function
      • 15.11.7. Application
      • 15.11.8. End User
    • 15.12. Russia & CIS Pharma Supply Chain Digitalization Market
      • 15.12.1. Country Segmental Analysis
      • 15.12.2. Component
      • 15.12.3. Deployment Mode
      • 15.12.4. Technology
      • 15.12.5. Enterprise Size
      • 15.12.6. Function
      • 15.12.7. Application
      • 15.12.8. End User
    • 15.13. Rest of Europe Pharma Supply Chain Digitalization Market
      • 15.13.1. Component
      • 15.13.2. Component
      • 15.13.3. Deployment Mode
      • 15.13.4. Technology
      • 15.13.5. Enterprise Size
      • 15.13.6. Function
      • 15.13.7. Application
      • 15.13.8. End User
  • 16. Asia Pacific Pharma Supply Chain Digitalization Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. Asia Pacific Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Component
      • 16.3.2. Deployment Mode
      • 16.3.3. Technology
      • 16.3.4. Enterprise Size
      • 16.3.5. Function
      • 16.3.6. Application
      • 16.3.7. End User
      • 16.3.8. Country
        • 16.3.8.1. China
        • 16.3.8.2. India
        • 16.3.8.3. Japan
        • 16.3.8.4. South Korea
        • 16.3.8.5. Australia and New Zealand
        • 16.3.8.6. Indonesia
        • 16.3.8.7. Malaysia
        • 16.3.8.8. Thailand
        • 16.3.8.9. Vietnam
        • 16.3.8.10. Rest of Asia Pacific
    • 16.4. China Pharma Supply Chain Digitalization Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Component
      • 16.4.3. Deployment Mode
      • 16.4.4. Technology
      • 16.4.5. Enterprise Size
      • 16.4.6. Function
      • 16.4.7. Application
      • 16.4.8. End User
    • 16.5. India Pharma Supply Chain Digitalization Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Component
      • 16.5.3. Deployment Mode
      • 16.5.4. Technology
      • 16.5.5. Enterprise Size
      • 16.5.6. Function
      • 16.5.7. Application
      • 16.5.8. End User
    • 16.6. Japan Pharma Supply Chain Digitalization Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Component
      • 16.6.3. Deployment Mode
      • 16.6.4. Technology
      • 16.6.5. Enterprise Size
      • 16.6.6. Function
      • 16.6.7. Application
      • 16.6.8. End User
    • 16.7. South Korea Pharma Supply Chain Digitalization Market
      • 16.7.1. Country Segmental Analysis
      • 16.7.2. Component
      • 16.7.3. Deployment Mode
      • 16.7.4. Technology
      • 16.7.5. Enterprise Size
      • 16.7.6. Function
      • 16.7.7. Application
      • 16.7.8. End User
    • 16.8. Australia and New Zealand Pharma Supply Chain Digitalization Market
      • 16.8.1. Country Segmental Analysis
      • 16.8.2. Component
      • 16.8.3. Deployment Mode
      • 16.8.4. Technology
      • 16.8.5. Enterprise Size
      • 16.8.6. Function
      • 16.8.7. Application
      • 16.8.8. End User
    • 16.9. Indonesia Pharma Supply Chain Digitalization Market
      • 16.9.1. Country Segmental Analysis
      • 16.9.2. Component
      • 16.9.3. Deployment Mode
      • 16.9.4. Technology
      • 16.9.5. Enterprise Size
      • 16.9.6. Function
      • 16.9.7. Application
      • 16.9.8. End User
    • 16.10. Malaysia Pharma Supply Chain Digitalization Market
      • 16.10.1. Country Segmental Analysis
      • 16.10.2. Component
      • 16.10.3. Deployment Mode
      • 16.10.4. Technology
      • 16.10.5. Enterprise Size
      • 16.10.6. Function
      • 16.10.7. Application
      • 16.10.8. End User
    • 16.11. Thailand Pharma Supply Chain Digitalization Market
      • 16.11.1. Country Segmental Analysis
      • 16.11.2. Component
      • 16.11.3. Deployment Mode
      • 16.11.4. Technology
      • 16.11.5. Enterprise Size
      • 16.11.6. Function
      • 16.11.7. Application
      • 16.11.8. End User
    • 16.12. Vietnam Pharma Supply Chain Digitalization Market
      • 16.12.1. Country Segmental Analysis
      • 16.12.2. Component
      • 16.12.3. Deployment Mode
      • 16.12.4. Technology
      • 16.12.5. Enterprise Size
      • 16.12.6. Function
      • 16.12.7. Application
      • 16.12.8. End User
    • 16.13. Rest of Asia Pacific Pharma Supply Chain Digitalization Market
      • 16.13.1. Country Segmental Analysis
      • 16.13.2. Component
      • 16.13.3. Deployment Mode
      • 16.13.4. Technology
      • 16.13.5. Enterprise Size
      • 16.13.6. Function
      • 16.13.7. Application
      • 16.13.8. End User
  • 17. Middle East Pharma Supply Chain Digitalization Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Middle East Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Component
      • 17.3.2. Deployment Mode
      • 17.3.3. Technology
      • 17.3.4. Enterprise Size
      • 17.3.5. Function
      • 17.3.6. Application
      • 17.3.7. End User
      • 17.3.8. Country
        • 17.3.8.1. Turkey
        • 17.3.8.2. UAE
        • 17.3.8.3. Saudi Arabia
        • 17.3.8.4. Israel
        • 17.3.8.5. Rest of Middle East
    • 17.4. Turkey Pharma Supply Chain Digitalization Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Component
      • 17.4.3. Deployment Mode
      • 17.4.4. Technology
      • 17.4.5. Enterprise Size
      • 17.4.6. Function
      • 17.4.7. Application
      • 17.4.8. End User
    • 17.5. UAE Pharma Supply Chain Digitalization Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Component
      • 17.5.3. Deployment Mode
      • 17.5.4. Technology
      • 17.5.5. Enterprise Size
      • 17.5.6. Function
      • 17.5.7. Application
      • 17.5.8. End User
    • 17.6. Saudi Arabia Pharma Supply Chain Digitalization Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Component
      • 17.6.3. Deployment Mode
      • 17.6.4. Technology
      • 17.6.5. Enterprise Size
      • 17.6.6. Function
      • 17.6.7. Application
      • 17.6.8. End User
    • 17.7. Israel Pharma Supply Chain Digitalization Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Component
      • 17.7.3. Deployment Mode
      • 17.7.4. Technology
      • 17.7.5. Enterprise Size
      • 17.7.6. Function
      • 17.7.7. Application
      • 17.7.8. End User
    • 17.8. Rest of Middle East Pharma Supply Chain Digitalization Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Component
      • 17.8.3. Deployment Mode
      • 17.8.4. Technology
      • 17.8.5. Enterprise Size
      • 17.8.6. Function
      • 17.8.7. Application
      • 17.8.8. End User
  • 18. Africa Pharma Supply Chain Digitalization Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Africa Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Component
      • 18.3.2. Deployment Mode
      • 18.3.3. Technology
      • 18.3.4. Enterprise Size
      • 18.3.5. Function
      • 18.3.6. Application
      • 18.3.7. End User
      • 18.3.8. Country
        • 18.3.8.1. South Africa
        • 18.3.8.2. Egypt
        • 18.3.8.3. Nigeria
        • 18.3.8.4. Algeria
        • 18.3.8.5. Rest of Africa
    • 18.4. South Africa Pharma Supply Chain Digitalization Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Component
      • 18.4.3. Deployment Mode
      • 18.4.4. Technology
      • 18.4.5. Enterprise Size
      • 18.4.6. Function
      • 18.4.7. Application
      • 18.4.8. End User
    • 18.5. Egypt Pharma Supply Chain Digitalization Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Component
      • 18.5.3. Deployment Mode
      • 18.5.4. Technology
      • 18.5.5. Enterprise Size
      • 18.5.6. Function
      • 18.5.7. Application
      • 18.5.8. End User
    • 18.6. Nigeria Pharma Supply Chain Digitalization Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Component
      • 18.6.3. Deployment Mode
      • 18.6.4. Technology
      • 18.6.5. Enterprise Size
      • 18.6.6. Function
      • 18.6.7. Application
      • 18.6.8. End User
    • 18.7. Algeria Pharma Supply Chain Digitalization Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Component
      • 18.7.3. Deployment Mode
      • 18.7.4. Technology
      • 18.7.5. Enterprise Size
      • 18.7.6. Function
      • 18.7.7. Application
      • 18.7.8. End User
    • 18.8. Rest of Africa Pharma Supply Chain Digitalization Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Component
      • 18.8.3. Deployment Mode
      • 18.8.4. Technology
      • 18.8.5. Enterprise Size
      • 18.8.6. Function
      • 18.8.7. Application
      • 18.8.8. End User
  • 19. South America Pharma Supply Chain Digitalization Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. South America Pharma Supply Chain Digitalization Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Component
      • 19.3.2. Deployment Mode
      • 19.3.3. Technology
      • 19.3.4. Enterprise Size
      • 19.3.5. Function
      • 19.3.6. Application
      • 19.3.7. End User
      • 19.3.8. Country
        • 19.3.8.1. Brazil
        • 19.3.8.2. Argentina
        • 19.3.8.3. Rest of South America
    • 19.4. Brazil Pharma Supply Chain Digitalization Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Component
      • 19.4.3. Deployment Mode
      • 19.4.4. Technology
      • 19.4.5. Enterprise Size
      • 19.4.6. Function
      • 19.4.7. Application
      • 19.4.8. End User
    • 19.5. Argentina Pharma Supply Chain Digitalization Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Component
      • 19.5.3. Deployment Mode
      • 19.5.4. Technology
      • 19.5.5. Enterprise Size
      • 19.5.6. Function
      • 19.5.7. Application
      • 19.5.8. End User
    • 19.6. Rest of South America Pharma Supply Chain Digitalization Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Component
      • 19.6.3. Deployment Mode
      • 19.6.4. Technology
      • 19.6.5. Enterprise Size
      • 19.6.6. Function
      • 19.6.7. Application
      • 19.6.8. End User
  • 20. Key Players/ Company Profile
    • 20.1. Blue Yonder Group, Inc.
      • 20.1.1. Company Details/ Overview
      • 20.1.2. Company Financials
      • 20.1.3. Key Customers and Competitors
      • 20.1.4. Business/ Industry Portfolio
      • 20.1.5. Product Portfolio/ Specification Details
      • 20.1.6. Strategic Overview
      • 20.1.7. Recent Developments
    • 20.2. Infosys Limited
    • 20.3. International Business Machines Corporation (IBM)
    • 20.4. Kinaxis Inc.
    • 20.5. Körber Supply Chain Software GmbH
    • 20.6. Manhattan Associates, Inc.
    • 20.7. Microsoft Corporation
    • 20.8. Oracle Corporation
    • 20.9. SAP SE
    • 20.10. Siemens Digital Industries Software
    • 20.11. Tecsys Inc.
    • 20.12. TraceLink Inc.
    • 20.13. Wipro Limited
    • 20.14. Other Key Players

 

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation